XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Oct. 31, 2024
Apr. 30, 2024
Current assets:    
Cash and cash equivalents $ 2,092 $ 3,151
Accounts receivable 1,785 796
Contract assets 86 18
Inventory 4,774 4,831
Other current assets 683 1,747
Total current assets 9,420 10,543
Property and equipment, net 3,292 3,443
Intangibles, net 3,556 3,622
Right-of-use assets, net 1,987 2,405
Restricted cash, long-term 154 154
Goodwill 8,537 8,537
Total assets 26,946 28,704
Current liabilities:    
Accounts payable 351 3,366
Earnout payable 400 1,130
Accrued expenses 1,428 1,787
Right-of-use liabilities, current portion 1,081 774
Contract liabilities 119 302
Total current liabilities 3,379 7,359
Deferred tax liability 203 203
Right-of-use liabilities, less current portion 1,245 1,798
Total liabilities 4,827 9,360
Commitments and contingencies (Note 14)
Shareholders’ Equity:    
Preferred stock, $0.001 par value; authorized 5,000,000 shares, none issued or outstanding; 100,000 designated as Series A
Common stock, $0.001 par value; authorized 200,000,000 shares, issued 124,683,555 shares and 61,352,731 shares, respectively; outstanding 124,595,538 shares and 61,264,714 shares, respectively 125 61
Treasury stock, at cost; 88,017 and 88,017 shares, respectively (369) (369)
Additional paid-in capital 338,352 327,276
Accumulated deficit (315,944) (307,579)
Accumulated other comprehensive loss (45) (45)
Total shareholders’ equity 22,119 19,344
Total liabilities and shareholders’ equity $ 26,946 $ 28,704